SCHEMBL6430692

SCHEMBL6430692

Cn1ncc(-c2ccc(F)cc2)c1/C=C/C(=O)Nc1ccc(CO[PH](=O)OCc2ccc(NC(=O)/C=C/c3c(-c4ccc(F)cc4)cnn3C)cc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNC P24863 3/20 0.41
CDK8 P49336 3/20 0.41
CDK19 Q9BWU1 1/20 0.41
MMP1 P03956 4/20 0.39
MMP2 P08253 4/20 0.39
MMP9 P14780 4/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
LMNA P02545 1/20 0.39
S1PR2 O95136 5/20 0.39
KDM4E B2RXH2 1/20 0.38
EGFR P00533 1/20 0.38
HPSE Q9Y251 2/20 0.37
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
CYP3A4 P08684 1/20 0.36
GAA P10253 1/20 0.36
CYP2C19 P33261 1/20 0.36
TP53 P04637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6430688 0.94 CCNC (0.40) CCNCCDK8CDK19MMP1MMP2
SCHEMBL6430695 0.94 CCNC (0.40) CCNCCDK8CDK19MMP1MMP2
SCHEMBL29208304 0.86 CCNC (0.43) CCNCCDK8CDK19MMP1MMP2
SCHEMBL6434501 0.86 CCNC (0.43) CCNCCDK8CDK19MMP1MMP2
SCHEMBL4836586 0.83 CCNC (0.42) CCNCCDK8CDK19MMP1MMP2
SCHEMBL4836584 0.83 CCNC (0.42) CCNCCDK8CDK19MMP1MMP2
SCHEMBL4829130 0.81 BTK (0.41) CCNCCDK8CDK19MMP1MMP2
SCHEMBL6434499 0.80 CCNC (0.42) CCNCCDK8CDK19MMP1MMP2
SCHEMBL6434504 0.80 CCNC (0.42) CCNCCDK8CDK19MMP1MMP2
SCHEMBL29208306 0.80 CCNC (0.42) CCNCCDK8CDK19MMP1MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1556032-A1 AGENT FOR PREVENTING OR TREATING NEUROPATHY Takeda Pharmaceutical Company Limited (JP) 2005-07-27 EP disclosed
WO-2004039365-A1 AGENT FOR PREVENTING OR TREATING NEUROPATHY TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-05-13 WO disclosed